SV Health Investors
Jamil M. Beg is an accomplished biotechnology professional and investor with extensive experience in founding and leading clinical stage companies, including Nido Biosciences, a precision neuroscience firm, and Kinaset Therapeutics, focused on inhaled therapeutics for respiratory diseases. Currently serving as a Partner at SV Health Investors, Jamil is also involved as a Founding Investor and Board member at Renasant Bio. Previously, Jamil held CEO and Partner roles at 5AM Ventures, contributing to early-stage life sciences investments, and served as a Board Observer for several emerging companies. Jamil M. Beg holds multiple degrees from the University of Pennsylvania and The Wharton School, including a Master of Biotechnology and an MBA in Health Care Management.
This person is not in any teams
SV Health Investors
SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm.Their goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who create and build breakthrough companies and treatments.With over $2 billion in capital under management inseven private healthcare funds, a 20-year track record in the US and Europe and offices in Boston, San Francisco and London, SV Health Investors drives game-changing innovation.